- •Preface
- •Acknowledgments
- •Contents
- •1.1 Introduction
- •1.2 Normal Embryology
- •1.3 Abnormalities of the Kidney
- •1.3.1 Renal Agenesis
- •1.3.2 Renal Hypoplasia
- •1.3.3 Supernumerary Kidneys
- •1.3.5 Polycystic Kidney Disease
- •1.3.6 Simple (Solitary) Renal Cyst
- •1.3.7 Renal Fusion and Renal Ectopia
- •1.3.8 Horseshoe Kidney
- •1.3.9 Crossed Fused Renal Ectopia
- •1.4 Abnormalities of the Ureter
- •1.5 Abnormalities of the Bladder
- •1.6 Abnormalities of the Penis and Urethra in Males
- •1.7 Abnormalities of Female External Genitalia
- •Further Reading
- •2.1 Introduction
- •2.2 Pathophysiology
- •2.3 Etiology of Hydronephrosis
- •2.5 Clinical Features
- •2.6 Investigations and Diagnosis
- •2.7 Treatment
- •2.8 Antenatal Hydronephrosis
- •Further Reading
- •3.1 Introduction
- •3.2 Embryology
- •3.3 Pathophysiology
- •3.4 Etiology of PUJ Obstruction
- •3.5 Clinical Features
- •3.6 Diagnosis and Investigations
- •3.7 Management of Newborns with PUJ Obstruction
- •3.8 Treatment
- •3.9 Post-operative Complications and Follow-Up
- •Further Reading
- •4: Renal Tumors in Children
- •4.1 Introduction
- •4.2 Wilms’ Tumor
- •4.2.1 Introduction
- •4.2.2 Etiology
- •4.2.3 Histopathology
- •4.2.4 Nephroblastomatosis
- •4.2.5 Clinical Features
- •4.2.6 Risk Factors for Wilms’ Tumor
- •4.2.7 Staging of Wilms Tumor
- •4.2.8 Investigations
- •4.2.9 Prognosis and Complications of Wilms Tumor
- •4.2.10 Surgical Considerations
- •4.2.11 Surgical Complications
- •4.2.12 Prognosis and Outcome
- •4.2.13 Extrarenal Wilms’ Tumors
- •4.3 Mesoblastic Nephroma
- •4.3.1 Introduction
- •4.3.3 Epidemiology
- •4.3.5 Clinical Features
- •4.3.6 Investigations
- •4.3.7 Treatment and Prognosis
- •4.4 Clear Cell Sarcoma of the Kidney (CCSK)
- •4.4.1 Introduction
- •4.4.2 Pathophysiology
- •4.4.3 Clinical Features
- •4.4.4 Investigations
- •4.4.5 Histopathology
- •4.4.6 Treatment
- •4.4.7 Prognosis
- •4.5 Malignant Rhabdoid Tumor of the Kidney
- •4.5.1 Introduction
- •4.5.2 Etiology and Pathophysiology
- •4.5.3 Histologic Findings
- •4.5.4 Clinical Features
- •4.5.5 Investigations and Diagnosis
- •4.5.6 Treatment and Outcome
- •4.5.7 Mortality/Morbidity
- •4.6 Renal Cell Carcinoma in Children
- •4.6.1 Introduction
- •4.6.2 Histopathology
- •4.6.4 Staging
- •4.6.5 Clinical Features
- •4.6.6 Investigations
- •4.6.7 Management
- •4.6.8 Prognosis
- •4.7 Angiomyolipoma of the Kidney
- •4.7.1 Introduction
- •4.7.2 Histopathology
- •4.7.4 Clinical Features
- •4.7.5 Investigations
- •4.7.6 Treatment and Prognosis
- •4.8 Renal Lymphoma
- •4.8.1 Introduction
- •4.8.2 Etiology and Pathogenesis
- •4.8.3 Diagnosis
- •4.8.4 Clinical Features
- •4.8.5 Treatment and Prognosis
- •4.9 Ossifying Renal Tumor of Infancy
- •4.10 Metanephric Adenoma
- •4.10.1 Introduction
- •4.10.2 Histopathology
- •4.10.3 Diagnosis
- •4.10.4 Clinical Features
- •4.10.5 Treatment
- •4.11 Multilocular Cystic Renal Tumor
- •Further Reading
- •Wilms’ Tumor
- •Mesoblastic Nephroma
- •Renal Cell Carcinoma in Children
- •Angiomyolipoma of the Kidney
- •Renal Lymphoma
- •Ossifying Renal Tumor of Infancy
- •Metanephric Adenoma
- •Multilocular Cystic Renal Tumor
- •5.1 Introduction
- •5.2 Embryology
- •5.4 Histologic Findings
- •5.7 Associated Anomalies
- •5.8 Clinical Features
- •5.9 Investigations
- •5.10 Treatment
- •Further Reading
- •6: Congenital Ureteral Anomalies
- •6.1 Etiology
- •6.2 Clinical Features
- •6.3 Investigations and Diagnosis
- •6.4 Duplex (Duplicated) System
- •6.4.1 Introduction
- •6.4.3 Clinical Features
- •6.4.4 Investigations
- •6.4.5 Treatment and Prognosis
- •6.5 Ectopic Ureter
- •6.5.1 Introduction
- •6.5.3 Clinical Features
- •6.5.4 Diagnosis
- •6.5.5 Surgical Treatment
- •6.6 Ureterocele
- •6.6.1 Introduction
- •6.6.3 Clinical Features
- •6.6.4 Investigations and Diagnosis
- •6.6.5 Treatment
- •6.6.5.1 Surgical Interventions
- •6.8 Mega Ureter
- •Further Reading
- •7: Congenital Megaureter
- •7.1 Introduction
- •7.3 Etiology and Pathophysiology
- •7.4 Clinical Presentation
- •7.5 Investigations and Diagnosis
- •7.6 Treatment and Prognosis
- •7.7 Complications
- •Further Reading
- •8.1 Introduction
- •8.2 Pathophysiology
- •8.4 Etiology of VUR
- •8.5 Clinical Features
- •8.6 Investigations
- •8.7 Management
- •8.7.1 Medical Treatment of VUR
- •8.7.2 Antibiotics Used for Prophylaxis
- •8.7.3 Anticholinergics
- •8.7.4 Surveillance
- •8.8 Surgical Therapy of VUR
- •8.8.1 Indications for Surgical Interventions
- •8.8.2 Indications for Surgical Interventions Based on Age at Diagnosis and the Presence or Absence of Renal Lesions
- •8.8.3 Endoscopic Injection
- •8.8.4 Surgical Management
- •8.9 Mortality/Morbidity
- •Further Reading
- •9: Pediatric Urolithiasis
- •9.1 Introduction
- •9.2 Etiology
- •9.4 Clinical Features
- •9.5 Investigations
- •9.6 Complications of Urolithiasis
- •9.7 Management
- •Further Reading
- •10.1 Introduction
- •10.2 Embryology of Persistent Müllerian Duct Syndrome
- •10.3 Etiology and Inheritance of PMDS
- •10.5 Clinical Features
- •10.6 Treatment
- •10.7 Prognosis
- •Further Reading
- •11.1 Introduction
- •11.2 Physiology and Bladder Function
- •11.2.1 Micturition
- •11.3 Pathophysiological Changes of NBSD
- •11.4 Etiology and Clinical Features
- •11.5 Investigations and Diagnosis
- •11.7 Management
- •11.8 Clean Intermittent Catheterization
- •11.9 Anticholinergics
- •11.10 Botulinum Toxin Type A
- •11.11 Tricyclic Antidepressant Drugs
- •11.12 Surgical Management
- •Further Reading
- •12.1 Introduction
- •12.2 Etiology
- •12.3 Pathophysiology
- •12.4 Clinical Features
- •12.5 Investigations and Diagnosis
- •12.6 Management
- •Further Reading
- •13.1 Introduction
- •13.2 Embryology
- •13.3 Epispadias
- •13.3.1 Introduction
- •13.3.2 Etiology
- •13.3.4 Treatment
- •13.3.6 Female Epispadias
- •13.3.7 Surgical Repair of Female Epispadias
- •13.3.8 Prognosis
- •13.4 Bladder Exstrophy
- •13.4.1 Introduction
- •13.4.2 Associated Anomalies
- •13.4.3 Principles of Surgical Management of Bladder Exstrophy
- •13.4.4 Evaluation and Management
- •13.5 Cloacal Exstrophy
- •13.5.1 Introduction
- •13.5.2 Skeletal Changes in Cloacal Exstrophy
- •13.5.3 Etiology and Pathogenesis
- •13.5.4 Prenatal Diagnosis
- •13.5.5 Associated Anomalies
- •13.5.8 Surgical Reconstruction
- •13.5.9 Management of Urinary Incontinence
- •13.5.10 Prognosis
- •13.5.11 Complications
- •Further Reading
- •14.1 Introduction
- •14.2 Etiology
- •14.3 Clinical Features
- •14.4 Associated Anomalies
- •14.5 Diagnosis
- •14.6 Treatment and Prognosis
- •Further Reading
- •15: Cloacal Anomalies
- •15.1 Introduction
- •15.2 Associated Anomalies
- •15.4 Clinical Features
- •15.5 Investigations
- •Further Reading
- •16: Urachal Remnants
- •16.1 Introduction
- •16.2 Embryology
- •16.4 Clinical Features
- •16.5 Tumors and Urachal Remnants
- •16.6 Management
- •Further Reading
- •17: Inguinal Hernias and Hydroceles
- •17.1 Introduction
- •17.2 Inguinal Hernia
- •17.2.1 Incidence
- •17.2.2 Etiology
- •17.2.3 Clinical Features
- •17.2.4 Variants of Hernia
- •17.2.6 Treatment
- •17.2.7 Complications of Inguinal Herniotomy
- •17.3 Hydrocele
- •17.3.1 Embryology
- •17.3.3 Treatment
- •Further Reading
- •18: Cloacal Exstrophy
- •18.1 Introduction
- •18.2 Etiology and Pathogenesis
- •18.3 Associated Anomalies
- •18.4 Clinical Features and Management
- •Further Reading
- •19: Posterior Urethral Valve
- •19.1 Introduction
- •19.2 Embryology
- •19.3 Pathophysiology
- •19.5 Clinical Features
- •19.6 Investigations and Diagnosis
- •19.7 Management
- •19.8 Medications Used in Patients with PUV
- •19.10 Long-Term Outcomes
- •19.10.3 Bladder Dysfunction
- •19.10.4 Renal Transplantation
- •19.10.5 Fertility
- •Further Reading
- •20.1 Introduction
- •20.2 Embryology
- •20.4 Clinical Features
- •20.5 Investigations
- •20.6 Treatment
- •20.7 The Müllerian Duct Cyst
- •Further Reading
- •21: Hypospadias
- •21.1 Introduction
- •21.2 Effects of Hypospadias
- •21.3 Embryology
- •21.4 Etiology of Hypospadias
- •21.5 Associated Anomalies
- •21.7 Clinical Features of Hypospadias
- •21.8 Treatment
- •21.9 Urinary Diversion
- •21.10 Postoperative Complications
- •Further Reading
- •22: Male Circumcision
- •22.1 Introduction
- •22.2 Anatomy and Pathophysiology
- •22.3 History of Circumcision
- •22.4 Pain Management
- •22.5 Indications for Circumcision
- •22.6 Contraindications to Circumcision
- •22.7 Surgical Procedure
- •22.8 Complications of Circumcision
- •Further Reading
- •23: Priapism in Children
- •23.1 Introduction
- •23.2 Pathophysiology
- •23.3 Etiology
- •23.5 Clinical Features
- •23.6 Investigations
- •23.7 Management
- •23.8 Prognosis
- •23.9 Priapism and Sickle Cell Disease
- •23.9.1 Introduction
- •23.9.2 Epidemiology
- •23.9.4 Pathophysiology
- •23.9.5 Clinical Features
- •23.9.6 Treatment
- •23.9.7 Prevention of Stuttering Priapism
- •23.9.8 Complications of Priapism and Prognosis
- •Further Reading
- •24.1 Introduction
- •24.2 Embryology and Normal Testicular Development and Descent
- •24.4 Causes of Undescended Testes and Risk Factors
- •24.5 Histopathology
- •24.7 Clinical Features and Diagnosis
- •24.8 Treatment
- •24.8.1 Success of Surgical Treatment
- •24.9 Complications of Orchidopexy
- •24.10 Infertility and Undescended Testes
- •24.11 Undescended Testes and the Risk of Cancer
- •Further Reading
- •25: Varicocele
- •25.1 Introduction
- •25.2 Etiology
- •25.3 Pathophysiology
- •25.4 Grading of Varicoceles
- •25.5 Clinical Features
- •25.6 Diagnosis
- •25.7 Treatment
- •25.8 Postoperative Complications
- •25.9 Prognosis
- •Further Reading
- •26.1 Introduction
- •26.2 Etiology and Risk Factors
- •26.3 Diagnosis
- •26.4 Intermittent Testicular Torsion
- •26.6 Effects of Testicular Torsion
- •26.7 Clinical Features
- •26.8 Treatment
- •26.9.1 Introduction
- •26.9.2 Etiology of Extravaginal Torsion
- •26.9.3 Clinical Features
- •26.9.4 Treatment
- •26.10 Torsion of the Testicular or Epididymal Appendage
- •26.10.1 Introduction
- •26.10.2 Embryology
- •26.10.3 Clinical Features
- •26.10.4 Investigations and Treatment
- •Further Reading
- •27: Testicular Tumors in Children
- •27.1 Introduction
- •27.4 Etiology of Testicular Tumors
- •27.5 Clinical Features
- •27.6 Staging
- •27.6.1 Regional Lymph Node Staging
- •27.7 Investigations
- •27.8 Treatment
- •27.9 Yolk Sac Tumor
- •27.10 Teratoma
- •27.11 Mixed Germ Cell Tumor
- •27.12 Stromal Tumors
- •27.13 Simple Testicular Cyst
- •27.14 Epidermoid Cysts
- •27.15 Testicular Microlithiasis (TM)
- •27.16 Gonadoblastoma
- •27.17 Cystic Dysplasia of the Testes
- •27.18 Leukemia and Lymphoma
- •27.19 Paratesticular Rhabdomyosarcoma
- •27.20 Prognosis and Outcome
- •Further Reading
- •28: Splenogonadal Fusion
- •28.1 Introduction
- •28.2 Etiology
- •28.4 Associated Anomalies
- •28.5 Clinical Features
- •28.6 Investigations
- •28.7 Treatment
- •Further Reading
- •29: Acute Scrotum
- •29.1 Introduction
- •29.2 Torsion of Testes
- •29.2.1 Introduction
- •29.2.3 Etiology
- •29.2.4 Clinical Features
- •29.2.5 Effects of Torsion of Testes
- •29.2.6 Investigations
- •29.2.7 Treatment
- •29.3 Torsion of the Testicular or Epididymal Appendage
- •29.3.1 Introduction
- •29.3.2 Embryology
- •29.3.3 Clinical Features
- •29.3.4 Investigations and Treatment
- •29.4.1 Introduction
- •29.4.2 Etiology
- •29.4.3 Clinical Features
- •29.4.4 Investigations and Treatment
- •29.5 Idiopathic Scrotal Edema
- •29.6 Testicular Trauma
- •29.7 Other Causes of Acute Scrotum
- •29.8 Splenogonadal Fusion
- •Further Reading
- •30.1 Introduction
- •30.2 Imperforate Hymen
- •30.3 Vaginal Atresia
- •30.5 Associated Anomalies
- •30.6 Embryology
- •30.7 Clinical Features
- •30.8 Investigations
- •30.9 Management
- •Further Reading
- •31: Disorders of Sexual Development
- •31.1 Introduction
- •31.2 Embryology
- •31.3 Sexual and Gonadal Differentiation
- •31.5 Evaluation of a Newborn with DSD
- •31.6 Diagnosis and Investigations
- •31.7 Management of Patients with DSD
- •31.8 Surgical Corrections of DSD
- •31.9 Congenital Adrenal Hyperplasia (CAH)
- •31.10 Androgen Insensitivity Syndrome (Testicular Feminization Syndrome)
- •31.13 Gonadal Dysgenesis
- •31.15 Ovotestis Disorders of Sexual Development
- •31.16 Other Rare Disorders of Sexual Development
- •Further Reading
- •Index
2.3 Etiology of Hydronephrosis |
|
|
49 |
|
|
|
|
|
|
• |
This will lead to compression of the |
|
• |
Renal scarring |
|
papillae, thinning of the parenchyma |
|
• |
Calculus formation |
|
around the calyces, and coalescence of |
|
• |
Sepsis |
|
the septa between calyces. |
|
• Loss of renal function |
|
• Eventually, cortical atrophy progresses |
|
– Longstanding hydronephrosis may be |
||
|
to the point at which only a thin rim of |
|
associated with obstructive nephropathy, |
|
|
parenchyma is present. |
|
hypertension and renal failure. |
|
• Fibrotic changes and increased collagen |
|
|
|
|
|
deposition are also observed in the peri- |
|
|
|
|
2.3 |
Etiology of Hydronephrosis |
||
|
tubular interstitium. |
|||
• |
The extrarenal dilatation can progress |
|
|
|
|
leading to ureteral dilatation to the point |
• The etiology and presentation of hydronephrosis |
||
|
of tortuosity. |
|
and/or hydroureter in adults differ from that in |
|
– Urinary stasis in these patients may result |
|
neonates and children (Figs. 2.15, 2.16, 2.17, |
||
in complications including: |
2.18, 2.19, 2.20, 2.21, 2.22, 2.23, 2.24, 2.25, 2.26, |
|||
• |
Infection |
|
2.27, 2.28, 2.29, 2.30, 2.31, 2.32, 2.33, and 2.34). |
Figs. 2.13 and 2.14 Intraoperative photographs showing atrophic kidneys secondary to severe reflux and hydroureters
Figs. 2.15 and 2.16 Intravenous urography showing bilateral hydroureters and hydronehrosis secondary to exteral compression by a distended vagina and uterus
(hydrometrocolpos) secondary to vaginal atresia. This will resolve once the vaginal atresia is treated
50 |
2 Hydronephrosis in Infants and Children |
|
|
Figs. 2.17, 2.18, and 2.19 MRI showing bilateral hydronephrosis and distended vagina secondary to vaginal atresia
DISTENDED UTERUS
Figs. 2.20 and 2.21 Inra-operative photographs showing hydrometrocolpos secondary to vaginal atresia. The distended vagina and uterus will lead to compression on
the ureters leading to hydroureteronephrosis. Drainage of the hydrometrocolpos will lead to relief of the obstruction and resolution of the hydroureteronephrosis
Figs. 2.22 and 2.23 Plain abdominal x-ray and IVU showing a staghorn stone in a child causing hydronephrosis. The stone took the shape of the renal pelvis and cayces. Note the stone is causing obstruction and hydronephrosis on the IVU
2.3 Etiology of Hydronephrosis |
51 |
|
|
Figs. 2.24, 2.25, and 2.26 Intravenous urogram and voiding cystourethrogrms showing unilateral hydroureteronephrosis secondary to uretrovesical obstruction and posterior urethral valve
Figs. 2.27 and 2.28 A voiding cystourethrogram showing urethral stricture causing vesicoureteral reflux with hydroureter and hydronephrosis
52 |
2 Hydronephrosis in Infants and Children |
|
|
DILATED
URETEROCELEE URETER
Figs. 2.29, 2.30, 2.31, and 2.32 Abdominal and pelvic ultrasound and CT-scan showing right and left uretrocele with hydroureter and hydronephrosis
•The causes of hydronephrosis with or without hydroureter depends on:
–The site of obstruction
–Whether it is unilateral or bilateral
–Whether it is intrinsic, extrinsic or functional.
•The following are the main causes of hydronephrosis in infants and children:
–Pelvi-ureteric junction obstruction
–Ureterovesical junction obstruction
–Ureteral folds and valves
–Benign fibroepithelial polyps
–Retrocaval ureter
–Neurogenic bladder
–Hydrocolpos and hydrometrocolpos
–Bladder exstrophy
–Duplicated renal collecting systems
–Multi cystic dysplastic kidney
–Retroperitoneal lymphoma and sarcoma
–Retroperitoneal fibrosis
–Renal, bladder and ureteric calculi
–Vesicoureteric reflux
–Posterior urethral valve
–Urethral stricture
–Uretrocele
–Posterior urethral valves
–Urethral atresia
–Phimosis and meatal stenosis
•Multi cystic dysplastic kidney (MCDK) (Figs. 2.35, 2.36, and 2.37):
–This will show several round, well defined, cystic structures within the kidney that often look just like severe hydronephrosis.
–These abnormally developed kidneys are generally found early in pregnancy through antenatal ultrasounds.
–The true diagnosis can be confirmed postnatally by the following tests:
2.3 Etiology of Hydronephrosis |
53 |
|
|
URETROCELE
ATROPHIC
KIDNEY
URETROCELE
DILATED URETER
Figs. 2.33 and 2.34 A cystogram showing an uretrocele and intraoperative photograph showing a large ureterocel causing obstruction and marked hydroureter and atrophic dysplastic kidney
|
• A post-natal ultrasound |
|
|
• |
A voiding cystourethrogram |
|
• A nuclear renal scan |
|
|
– The renal scan confirms that the kidney has |
|
|
no function. |
|
|
– MCDKs have no function and will involute |
|
|
(shrink up) over time. |
|
|
– Rarely, these multi cystic dysplastic kid- |
|
|
neys needs to be removed for the following |
|
|
reasons: |
|
|
• Very large multi cystic dysplastic |
|
Fig. 2.35 CT-scan showing multicystic |
dysplastic |
kidney |
|
||
kidney |
• |
If they fail to involute |
|
• |
If they rupture |
54 |
2 Hydronephrosis in Infants and Children |
|
|
Figs. 2.36 and 2.37 Clinical photographs showing resected multicystic dysplastic kidneys
Figs. 2.38 and 2.39 Bilateral nephrostograms and CT-scan showing bilateral PUJ obstruction
•If they develop unmanageable high blood pressure
•If they are complicated by severe infection
•There are several congenital and acquired conditions that can lead to hydronephrosis in infants and children.
•Congenital causes:
–PUJ (Pelvi-Ureteric Junction) obstruction
–Posterior urethral valve
–Uretro-vesical junction (UVJ) obstruction
–Vesicoureteric reflux
–Abnormal polar vessels
–Uretrocele
–Primary megaureter
–Neurogenic bladder
–Severe meatal stenosis
•Acquired causes:
–Kidney and ureteric stones
–Blood clots
–Retroperitoneal fibrosis
–Urethral stricture
–Tumors
•In children and in neonates, the relative frequency of the causes of antenatal hydronephrosis has been determined to be as follows:
–Transient (48 %)
2.4 Classification of Hydronephrosis |
55 |
|
|
Figs. 2.40, 2.41, and 2.42 Abdominal CT-scan and nephrostograms showing unilateral hydronephrosis
–Physiologic (15 %)
–Ureteropelvic junction obstruction (11 %)
–Vesicoureteral reflux (9 %)
–Megaureter (4 %)
–Multicystic dysplastic kidney (2 %)
–Ureterocele (2 %)
–Posterior urethral valves (1 %)
2.4Classification
of Hydronephrosis (Figs. 2.38, 2.39, 2.40, 2.41, and 2.42)
•The widespread use of antenatal ultrasound revealed a significant structural fetal anomaly in 1 % of pregnancies.
56 |
2 Hydronephrosis in Infants and Children |
|
|
•The probability of detecting these abnormalities depends on the experience and skills of the sonographer.
•The distribution of these anomalies is as follows:
–50 % involve the central nervous system
–20 % are genitourinary
–15 % are gastrointestinal
–8 % are cardiopulmonary
•An abnormality involving the genitourinary tract may be expected in as many as 1 in 100 pregnancies.
•The prevalence of antenatally detected hydronephrosis (ANH) is variable depending on the gestational age, diagnostic criteria and skills of the radiographer and ranges from 0.6% to 5.4%.
•Among the genitourinary anomalies, hydronephrosis is the commonest anomaly detected antenatally.
•The causes and distribution of antenatally diagnosed hydronephrosis are as follows:
–Transient hydronephrosis (40–80 %)
– |
Pelviureteric |
junction |
obstruction |
|
(10–30 %) |
|
|
– |
Vesicoureteric reflux (10–20 %) |
||
– |
Vesicoureteric |
junction |
obstruction |
|
(5–10 %) |
|
|
–Multicystic dysplastic kidney (5 %)
–Duplex system (4–6 %)
–Posterior urethral valve (1–2 %)
–Others (Urethral atresia, Prune belly syndrome, etc.)
•There are several systems to grade and classify hydronephrosis.
•Hydronephrosis can be classified depending on the onset into:
–Acute
–Chronic
•Hydronephrosis is also classified depending on the degree of obstruction into:
–Complete
–Partial
•Hydronephrosis is also classified depending on the side into:
–Unilateral
–Bilateral
•Grading of antenatal hydronephrosis based on renal pelvis antero-posterior diameter:
–Mild
•Second trimester (4–6 mm)
•Third trimester (7–9 mm)
–Moderate
•Second trimester (7–10 mm)
•Third trimester (10–15 mm)
–Severe
– Second trimester (>10 mm)
– Third trimester (>15 mm)
|
Renal pelvis antero-posterior diameter |
|
Classification |
Second trimester |
Third trimester |
Mild |
4–6 mm |
7–9 mm |
|
|
|
Moderate |
7–10 mm |
10–15 mm |
Severe |
>10 mm |
>15 mm |
•The most common system used (Society of Fetal Ultrasound, SFU) was originally designed for grading neonatal and infant hydronephrosis:
–Grade 0:
•No dilatation, calyceal walls are opposed to each other
–Grade 1 (mild):
•Dilatation of the renal pelvis without dilatation of the calyces
•No parenchymal atrophy
–Grade 2 (mild):
•Dilatation of the renal pelvis (mild) and calyces (pelvicalyceal pattern is retained)
•No parenchymal atrophy
–Grade 3 (moderate):
•Moderate dilatation of the renal pelvis and calyces
•Blunting of fornicies and flattening of papillae
•Mild cortical thinning may be seen
–Grade 4 (severe):
•Gross dilatation of the renal pelvis and calyces, which appear ballooned
•Loss of borders between the renal pelvis and calyces
•Renal atrophy seen as cortical thinning